Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2009; 134(7): 311-315
DOI: 10.1055/s-0028-1123998
DOI: 10.1055/s-0028-1123998
Aktuelle Diagnostik & Therapie | Review article
Geburtshilfe, Hämatologie, Onkologie© Georg Thieme Verlag KG Stuttgart · New York
Hämatologische Neoplasien und solide Tumoren in der Schwangerschaft
Teil 1: Diagnostik und grundsätzliche TherapieoptionenHematologic neoplasias and solid tumors in pregnancy Part 1: diagnosis and principal treatment optionsFurther Information
Publication History
eingereicht: 6.8.2008
akzeptiert: 2.12.1008
Publication Date:
05 February 2009 (online)

Schlüsselwörter
hämatologische Neoplasien - solide Tumoren - Schwangerschaft
Keywords
hematological neoplasias - solid tumours - pregnancy
Literatur
- 1
Asker C, Norstedt B, Kallen B.
Use of antiemetic drugs during pregnancy in Sweden.
Eur
J Clin Pharmacol.
2005;
61
899-890
MissingFormLabel
- 2
Ault P, Kantarjian H, O’Brien S.
Pregnancy among patients with chronic myeloid leukemia treated
with imatinib.
J Clin Oncol.
2006;
24
1204-1208
MissingFormLabel
- 3
Aviles A, Neri N.
Hematological malignancies
and pregnancy: a final report of 84 children who received chemotherapy
in utero.
Clin Lymphoma.
2001;
2
173-177
MissingFormLabel
- 4
Aviles A, Neri N, Nambo M J.
Long-term evaluation of cardiac function in children who received
anthracyclines during pregnancy.
Ann Oncol.
2006;
17
286-288
MissingFormLabel
- 5 Braun-Falco O, Plewig G, Wolff H, Burgdorf W HC, Landthaler M (Hrsg). Dermatologie und Venerologie. Berlin; Springer 2005
MissingFormLabel
- 6 Briggs G G. Drugs in Pregnancy and Lactation. Baltimore; Williams & Wilkins 2005
MissingFormLabel
- 7
Cardonick E, Iacobucci A.
Use of chemotherapy
during human pregnancy.
Lancet Oncol.
2004;
5
283-291
MissingFormLabel
- 8
Collins J C, Liao S, Wile A G.
Surgical management of breast masses in pregnant women.
J
Reprod Med.
1995;
40
785-788
MissingFormLabel
- 9
De Wilde J P, Rivers A W, Price D L.
A review of the current use of magnetic
resonance imaging in pregnancy and safety implications for the fetus.
Prog Biophys Mol Biol.
2005;
87
335-353
MissingFormLabel
- 10
Ebert U, Löffler H, Kirch W.
Cytotoxic therapy and pregnancy.
Pharmacol Ther.
1997;
72
207-220
MissingFormLabel
- 11
Garcia-Bournissen F, Shrim A, Koren G.
Mother risk update. Safety of gadolinium during pregnancy.
Canad Family Phys.
2005;
52
309-310
MissingFormLabel
- 12
Glinoer D. et al .
Pregnancy in patients with mild thyroid
abnormalities: maternal and neonatal repercussions.
J
Clin Endocrinol Metab.
1991;
73
421-427
MissingFormLabel
- 13
Hahn K M, Johnson P H, Gordon N.
Treatment of pregnant breast cancer patients and outcomes of
children exposed to chemotherapy in utero.
Cancer.
2006;
107
1219-26
MissingFormLabel
- 14
Johannsson O, Loman N, Olsson H.
Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline
mutation carriers.
Lancet.
1998;
352
1359-1360
MissingFormLabel
- 15
Leiserowitz G S.
Adnexal masses in pregnancy: how often are
they malignant?.
Gynecol Oncol.
2006;
101
315
MissingFormLabel
- 16
Lishner M, Zemlickis D, Degendorfer P.
Maternal and fetal outcome following Hodgkin’s disease
in pregnancy.
Br J Cancer.
1992;
65
114-117
MissingFormLabel
- 17
Lynch C M, Holt D A.
Use of antibiotics
during pregnancy.
Am Fam Physician.
1991;
43
1365-1368
MissingFormLabel
- 18
Minter A, Malik R, Ledbetter L, Winokur T, Hawn M, Saif M.
Colon cancer in pregnancy.
Cancer Control.
2005;
12
196-202
MissingFormLabel
- 19
Morvillo V. et al .
Androgen receptors in human melanoma cell
lines IIB-MEL-LES and IIB-MEL-IAN and in human melanoma metastases.
Melanoma Res.
2002;
12
(6)
529-538
MissingFormLabel
- 20
Nagayama M, Watanabe Y, Nakashita S, Dodo Y.
Fast MR imaging in obstetrics.
Radiographics.
2002;
22
563-582
MissingFormLabel
- 21
Oto A, Ernst R D, Hughes D, Chaljub G, Saade G.
MR imaging in the triage of pregnant patients with acute abdominal
and pelvic pain.
Abdom Imaging.
2008;
, epub
ahead of print
MissingFormLabel
- 22
Papini E. et al .
Risk of malignancy in nonpalpable thyroid
nodules: predictive value of ultrasound and color-Doppler features.
J Clin Endocrinol Metab.
2002;
87
1941-1946
MissingFormLabel
- 23
Pereg D, Koren G, Lishner M.
The treatment of Hodgkin’s and non-Hodgkin’s
lymphoma in pregnancy.
Haematologica.
2007;
92
1230-1237
MissingFormLabel
- 24
Pereg D, Koren G, Lishner M.
Cancer in pregnancy: Gaps, challenges and solutions.
Cancer
Treat Rev.
2008;
34
302-311
MissingFormLabel
- 25
Pizzuto J, Aviles A, Noriega L.
Treatment of acute leukemia during pregnancy: presentation of
nine cases.
Cancer Treat Rep.
1980;
64
679-683
MissingFormLabel
- 26
Pye S M, Cortes J, Ault P, Rosti G, Apperley J F.
The effects of imatinib on pregnancy outcome.
Blood.
2008;
111
5505-5508
MissingFormLabel
- 27
Rudolph A M.
Effects of aspirin and acetaminophen in pregnancy and in the
newborn.
Arch Intern Med.
1981;
1341
358-63
MissingFormLabel
- 28 Schaefer C, Spielmann H, Vetter K. Arzneiverordnung in Schwangerschaft und Stillzeit. München; Urban & Fischer 2006
MissingFormLabel
- 29
Struve C W, Haupt S, Ohlen S.
Influence of frequency of previous pregnancies on the prevalence
of thyroid nodules in women without clinical evidence of thyroid
disease.
Thyroid.
1993;
3
7-9
MissingFormLabel
- 30
Shen T, Vortmeyer A, Zhuang Z.
High frequency of allelic loss of BRCA2 gene in pregnancy-associated
breast carcinoma.
J Natl Cancer Inst.
1999;
91
1686
MissingFormLabel
- 31
Watson W J.
Herceptin (trastuzumab) therapy during pregnancy: association
with reversible anhydramnions.
Obstet Gynecol.
2005;
105
642
MissingFormLabel
- 32
Weisz B, Meirow D, Schiff E, Lishner M.
Impact and treatment
of cancer during pregnancy.
Exp Rev Anticancer Ther.
2004;
4
889-902
MissingFormLabel
- 33
Yahalom J.
Treatment options for Hodgkin’s disease during pregnancy.
Leuk Lymphoma.
1990;
2
151-161
MissingFormLabel
Dr. med. Henning Popp
Medizinische Klinik und Poliklinik III, Klinikum
der Universität München – Großhadern
Marchioninistr. 15
81377 München
Email: Henning.Popp@med.uni-muenchen.de